title: Long term course of childhood epilepsy following relapse after antiepileptic drug withdrawal.
abstract: OBJECTIVE
  To explore the course of epilepsy following relapse after antiepileptic drug (AED) withdrawal.
  
  
  METHODS
  Forty two patients were identified with onset of epilepsy in childhood in whom AEDs had been withdrawn after at least 2 years of seizure freedom, and in whom a relapse had occurred. Two patients were lost to follow up.
  
  
  RESULTS
  Median follow up after AED withdrawal was 5.9 years (range 1.6-13.2 years). Relapse occurred in more than half of the patients within 6 months of AED withdrawal. At the end of follow up, 12 patients (30%) were seizure free for at least 1 year (mean 10.4 years) without medication; 16 (40%) were seizure free for at least 1 year (mean 5.3 years) with ongoing medication; and 12 patients (30%) were seizure free for less than 1 year with medication. No status epilepticus occurred in any patient after withdrawal. Age at onset, if over the age of 5, combined with normal intelligence were predictive of an excellent outcome; presence of a neurological disorder, and hence symptomatic aetiology, was predictive of poor outcome after a relapse.
  
  
  CONCLUSIONS
  Fears that premature withdrawal of AEDs might result in uncontrollable seizures were unsubstantiated in this study. The current practice of withdrawing AEDs in children who have been seizure free for 2 years can be beneficial to most of these patients.
authors.affiliation: Department of Neurology, Division of Child Neurology, Leiden University Medical Center, The Netherlands.
authors.forename: P A D
authors.initials: PA
authors.lastname: Bouma
authors.forename: A C B
authors.initials: AC
authors.lastname: Peters
authors.forename: O F
authors.initials: OF
authors.lastname: Brouwer
mesh_terms: D000293:Adolescent; D000328:Adult; D000927:Anticonvulsants / Q000008:administration & dosage*; D002648:Child; D002675:Child, Preschool; D015331:Cohort Studies; D004334:Drug Administration Schedule; D004827:Epilepsy / Q000188:drug therapy / Q000473:pathology*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D011379:Prognosis; D012008:Recurrence; D012640:Seizures
chemical_list: D000927:Anticonvulsants